Association of apolipoprotein e gene polymorphisms with blood lipids and their interaction with dietary factors

Lipids in Health and Disease

Volumn 17, Issue 1, 2018, Pages

  Shatwan, Israa M ^a,b   Winther, Kristian Hillert ^c   Ellahi, Basma ^d   Elwood, Peter ^e   Ben Shlomo, Yoav ^f   Givens, Ian ^a   Rayman, Margaret P ^g   Lovegrove, Julie A ^a   Vimaleswaran, Karani S ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF CHESTER   (United Kingdom)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

^g UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

APOE gene; Caerphilly prospective studies; LDL C; PRECISE; Total cholesterol

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; APOE PROTEIN, HUMAN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ALLELE; APOLIPOPROTEIN E GENE; APOLIPOPROTEIN E2 GENE; APOLIPOPROTEIN E3 GENE; APOLIPOPROTEIN E4 GENE; ARTICLE; BLOOD ANALYSIS; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN LIPASE GENE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TOTAL CHOLESTEROL LEVEL; BLOOD; CARDIOVASCULAR DISEASE; DIET; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; PATHOLOGY;

ALLELES; APOLIPOPROTEINS E; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES;

EID: 85046291588     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-018-0744-2     Document Type: Article

References (68)

1. Wang J, et al. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Eur Heart J. 2007;28(7):857-64.
2. McNeill AM, et al. Metabolic syndrome and cardiovascular disease in older people: the cardiovascular health study. J Am Geriatr Soc. 2006;54(9):1317-24.
3. Barter P, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med. 2007;357(13):1301-10.
4. Gotto AM Jr. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease. Am Heart J. 2002;144(6 Suppl):S33-42.
5. Forrester JS. Triglycerides: risk factor or fellow traveler? Curr Opin Cardiol. 2001;16(4):261-4.
6. Song Y, Stampfer MJ, Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med. 2004;141(2):137-47.
7. Ahmadzadeh A, Azizi F. Genes associated with low serum high-density lipoprotein cholesterol. Arch Iran Med. 2014;17(6):444-50.
8. Nettleton JA. Associations between HDL-cholesterol and polymorphisms in hepatic lipase and lipoprotein lipase genes are modified by dietary fat intake in African American and white adults. Atherosclerosis. 2007;194:e131-40.
9. Carvalho-Wells AL, et al. APOE genotype influences triglyceride and C-reactive protein responses to altered dietary fat intake in UK adults. Am J Clin Nutr. 2012;96(6):1447-53.
10. Couture P, et al. Influences of apolipoprotein E polymorphism on the response of plasma lipids to the ad libitum consumption of a high-carbohydrate diet compared with a high-monounsaturated fatty acid diet. Metabolism. 2003;52(11):1454-9.
11. Bennet AM, et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA. 2007;298(11):1300-11.
12. Radha V, et al. Association of lipoprotein lipase hind III and Ser 447 Ter polymorphisms with dyslipidemia in Asian Indians. Am J Cardiol. 2006;97(9):1337-42.
13. Shatwan IM, et al. Impact of lipoprotein lipase gene polymorphism, S447X, on postprandial triacylglycerol and glucose response to sequential meal ingestion. Int J Mol Sci. 2016;17(3):397.
14. Munshi A, et al. Association of LPL gene variant and LDL, HDL, VLDL cholesterol and triglyceride levels with ischemic stroke and its subtypes. J Neurol Sci. 2012;318(1-2):51-4.
15. Calabuig-Navarro MV, et al. Apolipoprotein E genotype has a modest impact on the postprandial plasma response to meals of varying fat composition in healthy men in a randomized controlled trial. J Nutr. 2014;144(11):1775-80.
16. Shahid SU, et al. Effect of SORT1, APOB and APOE polymorphisms on LDL-C and coronary heart disease in Pakistani subjects and their comparison with Northwick Park heart study II. Lipids Health Dis. 2016;15:83.
17. Wilson PW, et al. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease The Framingham Offspring Study. JAMA. 1994;272(21):1666-71.
18. Giger JN, et al. Genetic predictors of coronary heart disease risk factors in premenopausal African-American women. Ethn Dis. 2005;15(2):221-32.
19. Wang H, Eckel RH. Lipoprotein lipase: from gene to obesity. Am J Physiol Endocrinol Metab. 2009;297(2):E271-88.
20. Merkel M, Eckel RH, Goldberg IJ. Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res. 2002;43(12):1997-2006.
21. Friday KE, et al. Black-white differences in postprandial triglyceride response and postheparin lipoprotein lipase and hepatic triglyceride lipase among young men. Metabolism. 1999;48(6):749-54.
22. Nierman MC, et al. Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers. Arterioscler Thromb Vasc Biol. 2005;25(11):2410-5.
23. Rip J, et al. Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation. Arterioscler Thromb Vasc Biol. 2006;26(6):1236-45.
24. Lopez-Miranda J, et al. The influence of lipoprotein lipase gene variation on postprandial lipoprotein metabolism. J Clin Endocrinol Metab. 2004;89(9):4721-8.
25. Sagoo GS, et al. Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis. Am J Epidemiol. 2008;168(11):1233-46.
26. Ukkola O, et al. Genetic variation at the lipoprotein lipase locus and plasma lipoprotein and insulin levels in the Quebec family study. Atherosclerosis. 2001;158(1):199-206.
27. Ordovas JM. Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention. Am J Clin Nutr. 2009;89(5):1509s-17s.
28. Nettleton JA, et al. Associations between HDL-cholesterol and polymorphisms in hepatic lipase and lipoprotein lipase genes are modified by dietary fat intake in African American and white adults. Atherosclerosis. 2007;194(2):e131-40.
29. Wu K, et al. Apolipoprotein E polymorphisms, dietary fat and fibre, and serum lipids: the EPIC Norfolk study. Eur Heart J. 2007;28(23):2930-6.
30. Zhang C, et al. Interactions between the -514C->T polymorphism of the hepatic lipase gene and lifestyle factors in relation to HDL concentrations among US diabetic men. Am J Clin Nutr. 2005;81(6):1429-35.
31. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb. 1992;12(8):911-9.
32. Hwang JY, et al. Carbohydrate intake interacts with SNP276G>T polymorphism in the adiponectin gene to affect fasting blood glucose, HbA1C, and HDL cholesterol in Korean patients with type 2 diabetes. J Am Coll Nutr. 2013;32(3):143-50.
33. Cold F, et al. Randomised controlled trial of the effect of long-term selenium supplementation on plasma cholesterol in an elderly Danish population. Br J Nutr. 2015;114(11):1807-18.
34. Rayman MP, et al. A randomized trial of selenium supplementation and risk of type-2 diabetes, as assessed by plasma adiponectin. PLoS One. 2012;7(9):e45269.
35. McKeown NM, et al. Use of biological markers to validate self-reported dietary intake in a random sample of the European prospective investigation into Cancer United Kingdom Norfolk cohort. Am J Clin Nutr. 2001;74(2):188-96.
36. Mulligan AA, et al. A new tool for converting food frequency questionnaire data into nutrient and food group values: FETA research methods and availability. BMJ Open. 2014;4(3):e004503.
37. Komurcu-Bayrak E, et al. The APOE -219G/T and +113G/C polymorphisms affect insulin resistance among Turks. Metabolism. 2011;60(5):655-63.
38. Viiri LE, et al. Interactions of functional apolipoprotein E gene promoter polymorphisms with smoking on aortic atherosclerosis. Circ Cardiovasc Genet. 2008;1(2):107-16.
39. Son KY, et al. Genetic association of APOA5 and APOE with metabolic syndrome and their interaction with health-related behavior in Korean men. Lipids Health Dis. 2015;14:105.
40. Kring SI, et al. Impact of psychological stress on the associations between apolipoprotein E variants and metabolic traits: findings in an American sample of caregivers and controls. Psychosom Med. 2010;72(5):427-33.
41. Trompet S, et al. Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses. BMC Med Genet. 2011;12:131.
42. Zhang Z, et al. Association of genetic loci with blood lipids in the Chinese population. PLoS One. 2011;6(11):e27305.
43. Zhou L, et al. A genome wide association study identifies common variants associated with lipid levels in the Chinese population. PLoS One. 2013;8(12):e82420.
44. Seripa D, et al. TOMM40, APOE, and APOC1 in primary progressive aphasia and frontotemporal dementia. J Alzheimers Dis. 2012;31(4):731-40.
45. The Caerphilly and speedwell collaborative Group. Caerphilly and Speedwell collaborative heart disease studies. J Epidemiol Community Health. 1984;38(3):259-62.
46. Mertens E, et al. Dietary patterns in relation to cardiovascular disease incidence and risk markers in a middle-aged British male population: data from the Caerphilly prospective study. Nutrients. 2017;9(1):75.
47. Fehily AM, Yarnell JW, Butland BK. Diet and ischaemic heart disease in the Caerphilly study. Hum Nutr Appl Nutr. 1987;41(5):319-26.
48. Yarnell JW, et al. A short dietary questionnaire for use in an epidemiological survey: comparison with weighed dietary records. Hum Nutr Appl Nutr. 1983;37(2):103-12.
49. Yarnell JW, et al. Do total and high density lipoprotein cholesterol and triglycerides act independently in the prediction of ischemic heart disease? Ten-year follow-up of Caerphilly and speedwell cohorts. Arterioscler Thromb Vasc Biol. 2001;21(8):1340-5.
50. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502.
51. Voight BF, et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet. 2012;8(8):e1002793.
52. Shah T, et al. Population genomics of cardiometabolic traits: design of the University College London-London School of Hygiene and Tropical Medicine-Edinburgh-Bristol (UCLEB) consortium. PLoS One. 2013;8(8):e71345.
53. El-Lebedy D, Raslan HM, Mohammed AM, Apolipoprotein E. Gene polymorphism and risk of type 2 diabetes and cardiovascular disease. Cardiovasc Diabetol. 2016;15:12.
54. Ken-Dror G, et al. APOE/C1/C4/C2 gene cluster genotypes, haplotypes and lipid levels in prospective coronary heart disease risk among UK healthy men. Mol Med. 2010;16(9-10):389-99.
55. Mozas P, et al. Apolipoprotein E genotype is not associated with cardiovascular disease in heterozygous subjects with familial hypercholesterolemia. Am Heart J. 2003;145(6):999-1005.
56. Suwalak T, et al. Polymorphisms of the ApoE (apolipoprotein E) gene and their influence on dyslipidemia in HIV-1-infected individuals. Jpn J Infect Dis. 2015;68(1):5-12.
57. Eichner JE, et al. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol. 2002;155(6):487-95.
58. Jackson KG, et al. Saturated fat-induced changes in sf 60-400 particle composition reduces uptake of LDL by HepG2 cells. J Lipid Res. 2006;47(2):393-403.
59. Ehnholm C, et al. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. Proc Natl Acad Sci U S A. 1984;81(17):5566-70.
60. Gregg RE, et al. Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest. 1986;78(3):815-21.
61. Smith EN, et al. Longitudinal genome-wide association of cardiovascular disease risk factors in the Bogalusa heart study. PLoS Genet. 2010;6(9):e1001094.
62. Hellwege JN, et al. Genome-wide family-based linkage analysis of exome chip variants and cardiometabolic risk. Genet Epidemiol. 2014;38(4):345-52.
63. Deshmukh HA, et al. Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a). J Lipid Res. 2012;53(5):1000-11.
64. Sarkkinen E, et al. Effect of apolipoprotein E polymorphism on serum lipid response to the separate modification of dietary fat and dietary cholesterol. Am J Clin Nutr. 1998;68(6):1215-22.
65. Gylling H, Miettinen TA. Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men with different apoE phenotypes. J Lipid Res. 1992;33(9):1361-71.
66. Petkeviciene J, et al. Associations between apolipoprotein E genotype, diet, body mass index, and serum lipids in Lithuanian adult population. PLoS One. 2012;7(7):e41525.
67. Kaser S, et al. Phospholipid and cholesteryl ester transfer are increased in lipoprotein lipase deficiency. J Intern Med. 2003;253(2):208-16.
68. Humphries SE, et al. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European atherosclerosis research study (EARS). Arterioscler Thromb Vasc Biol. 1998;18(4):526-34.